Log In
Print
BCIQ
Print
Print this Print this
 

LK-1

  Manage Alerts
Collapse Summary General Information
Company Lykera Biomed S.A.
DescriptionHumanized mAb against S100 calcium binding protein A4 (S100A4)
Molecular Target S100 calcium binding protein A4 (S100A4)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today